OcuTerra Therapeutics is developing novel eye drop designed to treat diabetic eye disease.
OcuTerra Therapeutics, Inc. is developing innovative drugs for ophthalmic diseases for which the current standard of care does not prevent or control the progression of the disease.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 9, 2021 | Series B | $35M | — | — | — | Detail |
Jun 8, 2021 | Series B | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Robin Hood Ventures | — | Series B |